Professor Markus Buehler composed it, and a South Korean orchestra performed it; it’s the latest in a series of artistic collaborations sparked by Buehler’s exploration of the structure of SARS-CoV-2.
Case’s new lab investigates why cancer arises when disruptions in cellular organization change how cells sense mechanical forces.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
Astrocytes with the APOE4 gene variant show deficits of a key cellular function, but overexpressing the gene PICALM overcame the defect.
Automated tabletop machine could accelerate the development of novel drugs to treat cancer and other diseases.
Using engineered binder proteins to detect viral proteins or antibodies rather than RNA, new tests may overcome current challenges in testing for SARS-CoV-2 virus.
The protein Synaptotagmin 7 limits supply of neurotransmitter-containing vesicles for release at synapses.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
Translated into sound, SARS-CoV-2 tricks our ear in the same way the virus tricks our cells.
Engineered signaling pathways could offer a new way to build synthetic biology circuits.
Assistant professors Pulin Li and Seychelle Vos are investigating how cells become tissues and the proteins that organize DNA.
Solugen’s engineered enzymes offer a biologically-inspired method for producing the chemical.
New research reveals a structural model for amyloid fibrils that could aid in future medicinal interventions for Alzheimer's, CTE, and more.
Novel study shows protein CPG15 acts as a molecular proxy of experience to mark synapses for stabilization.
Whitehead Institute team finds drugs that activate a key brain gene; initial tests in cells and mice show promise for rare, untreatable neurodevelopmental disorder.